Skip to main content

Walleye Capital LLC

Position in QGEN — Qiagen N.V.

CIK 1758720 NEW YORK, NY

Position in QGEN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
12 quarters on record

Common Shares in QGEN Over Time

Shares Held

Position Value (USD)

Derivatives in QGEN

reported options exposure · as of Jun 30, 2026
CallValue
$93,840
CallShares
2,400
PutValue
$203,320
PutShares
5,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $25,239,598 across 16 Diagnostics & Research names.

# Ticker Company Shares Value (USD) Open

All Filings in QGEN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $93,840 2,400
2026-06-30 $203,320 5,200
2026-03-31 $112,112 2,800
2026-03-31 $976,976 24,400
2025-09-30 $31,276 700
2025-09-30 $379,780 8,500
2024-12-31 $419,828 9,428
2024-12-31 $200,385 4,500
2024-09-30 $86,583 1,900
2024-09-30 $225,480 4,948
2024-06-30 $43,144 1,050
2024-06-30 $49,308 1,200
2024-06-30 $394,464 9,600
2023-12-31 $607,258 13,549
2023-12-31 $94,120 2,100
2023-09-30 $296,749 7,100
2023-03-31 $457,593 9,654
2022-12-31 $761,790 14,802
2020-06-30 $1,766,256 39,979
2020-03-31 $1,635,152 38,088